Reported Oct 29, 2025 · Ongoing

Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc.,…

Lannett Company Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Lannett Company Inc. · 1101 C Ave W · Seymour, IN · 47274-3342

Is this the product you have?

  • Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle
  • Distributed byLannett Company, Inc., Philadelphia, PA 19136
  • NDC62175-322-46
Lot codes and dates
  • Lot
  • expiry
    • 21264027A
    • Exp 10/30/2025
    • 22266446A
    • Exp 12/31/2025
    • 22266901A
    • Exp 02/28/2026
    • 22267553A
    • 22267554A
    • Exp 03/31/2026
    • 22267555A
    • Exp 02/28/2026
    • 22267992A
    • Exp 04/30/2026
    • 22267993A
    • 22267994A
    • Exp 05/31/2026
Amount recalled
46,848 90-count bottles

Where it was sold

  • Nationwide

Why it was recalled

Failed Dissolution Specifications

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Lannett Company Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 8:05 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.